Trials / Completed
CompletedNCT00628940
PET Imaging of High-grade Glioma Using 18F-fluoromethylcholine: a Tool for the Early Detection of Tumour Recurrence After Combined Radiochemotherapy?
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- University Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to define preferential sites of tumour recurrence by observing tracer uptake in the tumour in sequential PET images with 18F-fluoromethylcholine (and perfusion MR, see also below). Changes in the intensity of the tracer uptake in the tumour during and after the course of radiotherapy will be correlated with the site of tumour recurrence as will be assessed by conventional MRI. In due time, these results must enable clinicians to change their therapeutic approach of high-grade glioma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | PET images with 18F-fluoromethylcholine | sequential PET images with 18F-fluoromethylcholine |
Timeline
- Start date
- 2010-01-12
- Primary completion
- 2017-03-14
- Completion
- 2018-03-22
- First posted
- 2008-03-05
- Last updated
- 2018-05-18
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00628940. Inclusion in this directory is not an endorsement.